Pfizer up 17% in US as Nexium 24HR advances

30 April 2015 - Deborah Wilkes

Pfizer Consumer Healthcare's US sales rose by 17% in the first quarter of 2015 following the launch of Nexium 24HR a year ago. Chief executive officer Ian Read said the business "is strategically important" to Pfizer.